US 12331293
Bispecific antisense oligonucleotides for dystrophin exon skipping
granted A61PA61P21/00
Quick answer
US patent 12331293 (Bispecific antisense oligonucleotides for dystrophin exon skipping) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P21/00